Linked Life Data

17608842

Source:http://linkedlifedata.com/resource/pubmed/id/17608842

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-7-4
pubmed:abstractText
The pathogenesis of Crohn's disease is unclear, but many studies suggest that luminal bacteria play an important role in chronic intestinal inflammation in patients with this condition. Clarithromycin is a macrolide antibiotic with immunomodulatory activity. The aim of this study was to evaluate the effect of clarithromycin therapy in Japanese patients with Crohn's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0815-9319
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
984-8
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease.
pubmed:affiliation
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't